Lisa N. Boggio, MD

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

1. American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty.
   Jacobs JJ, Mont MA, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG, Yates AC Jr, Boggio LN, Watters WC 3rd, Turkelson CM, Wies JL, Sluka P, Hitchcock K.
   J Bone Joint Surg Am. 2012
   2012 Apr 18
   94(8):746-7. doi: 10.2106/JBJS.9408.ebo746. No abstract available.
   
2. In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice
   Kidd S, Bueso-Ramos C, Jagan S, Paganessi LA, Boggio LN, Fung HC, Gregory SA, Christopherson KW 2nd
   Exp Hematol
   2011 Feb 1
   
3. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty.
   Mont MA, Jacobs JJ, Boggio LN, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG, Yates AJ Jr, Watters WC 3rd, Turkelson CM, Wies JL, Donnelly P, Patel N, Sluka P.
   J Am Acad Orthop Surg.
   2011 Dec
   19(12):768-76.
   
4. Argatroban use in heparin-induced thrombocytopenia
   Boggio LN, Oza VM
   Expert Opin Pharmacother
   2008 Aug
   9(11):1963-7
   

• To watch a brief video of Lisa N. Boggio, MD, click the play button at the lower left corner of the video frame below.
• (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
• View Transcript

• Patients come to see me if they have basically a bleeding problem, a blood clotting problem, or sometimes they have abnormal blood counts.

  Treatments are different for the different bleeding problems. So if you have a bleeding disorder, you’re missing a clotting factor. I give you back that clotting factor, and I put you back to even. If you have a blood clotting, or thrombosis problem, you have too much factor. And I give a blood thinner, and it comes back up to even. So that’s the goal of those therapies is just to even out the abnormal problem.